A carregar...

Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease

Hormone receptor positive (HR+) breast cancers are a heterogeneous class with differential prognosis. Although more than half of Indian women present with advanced disease, many such patients do well. We have attempted identification of biologically indolent tumors within HR+HER2- tumors based on ge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Oncol
Main Authors: Prabhu, Jyothi S, Korlimarla, Aruna, Anupama, C E, Alexander, Annie, Raghavan, Rohini, Kaul, Roma, Desai, Krisha, Rajarajan, Savitha, Manjunath, Suraj, Correa, Marjorrie, Raman, R, Kalamdani, Anjali, Prasad, MSN, Patil, Shekar, Gopinath, K S, Srinath, B S, Sridhar, T.S.
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5506875/
https://ncbi.nlm.nih.gov/pubmed/28704710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2017.04.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!